Fludarabine Phosphate
Who holds supplier records for Fludarabine Phosphate? 6 organisations hold a current record for Fludarabine Phosphate: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (3), Netherlands (1) and Switzerland (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Fludarabine Phosphate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/fludarabine-phosphate
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in China
3 of the 5 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Fludarabine Phosphate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTDChinaCEPActive DMF 34509, 21047 · latest filing Apr 2020
- TAPI NL BVNetherlandsCEPActive DMF 15742 · latest filing Nov 2001
- BIOCARE PHARMACEUTICAL LTDChinaActive DMF 35173 · latest filing Sept 2020
- EXPLORA LABORATORIES SASwitzerlandActive DMF 23006 · latest filing Aug 2009
- Zhejiang Hisun Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 16807 · latest filing Aug 2003
- CHONGQING BIOCARE PHARMACEUTICAL LTDCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (3)
Certificates of Suitability on the EDQM register for Fludarabine Phosphate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| TAPI NL B.V. Amsterdam | NL | CEP 2005-257 - Rev 06 Fludarabine phosphate | Jul 2025 | — |
| CHONGQING BIOCARE PHARMACEUTICAL LTD. Chongqing | CN | R0-CEP 2020-245 - Rev 01 Fludarabine phosphate | Jun 2022 | — |
| HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO., LTD. Jingmen City | CN | R0-CEP 2020-136 - Rev 01 Fludarabine phosphate | Jan 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (4)
Organisations whose Type II DMFs for Fludarabine Phosphate are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- Italy · Inactive DMF 17374 · filed May 2004
- United States · Inactive DMF 17136 · filed Jan 2004
- ASH STEVENS INCInactive DMF 15542, 8241 · filed Jul 2001
- Germany · Inactive DMF 14924 · filed Jun 2000
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Fludarabine Phosphate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1096882).
Chemical identity
- IUPAC name
- [(2R,3S,4S,5R)-5-(6-amino-2-fluoropurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
- Canonical SMILES
- C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)F)N
- InChIKey
- GIUYCYHIANZCFB-FJFJXFQQSA-N
- Synonyms
- 2-f-ara-amp, Fludara, Fludarabine 5'-monophosphate, Fludarabine monophosphate, Fludarabine phosphate, NSC-312887, NSC-328002, Oforta, NSC 312887, CHEBI:63599, 2F-ara-AMP, F-ara-AMP
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nucleoside Metabolic Inhibitor
- Mechanism of action
- Nucleic Acid Synthesis Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Fludarabine Phosphate?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Fludarabine Phosphate: HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD (China), TAPI NL BV (Netherlands), BIOCARE PHARMACEUTICAL LTD (China), EXPLORA LABORATORIES SA (Switzerland), Zhejiang Hisun Pharmaceutical Co., Ltd. (China) and CHONGQING BIOCARE PHARMACEUTICAL LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Fludarabine Phosphate Drug Master Files are active?
HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD (DMF 34509, 21047), TAPI NL BV (DMF 15742), BIOCARE PHARMACEUTICAL LTD (DMF 35173), EXPLORA LABORATORIES SA (DMF 23006) and Zhejiang Hisun Pharmaceutical Co., Ltd. (DMF 16807). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Fludarabine Phosphate records mean?
4 organisations have only inactive Type II DMFs for Fludarabine Phosphate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Fludarabine Phosphate have a European Certificate of Suitability?
Yes. 3 organisations hold a valid CEP for Fludarabine Phosphate on the EDQM register, including TAPI NL B.V. Amsterdam (NL), CHONGQING BIOCARE PHARMACEUTICAL LTD. Chongqing (CN) and HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO., LTD. Jingmen City (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Fludarabine Phosphate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Fludarabine Phosphate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.